Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 7/20 | 0.52 |
| ▸ | MAOB | P27338 | 7/20 | 0.52 |
| ▸ | PPARA | Q07869 | 8/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 7/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7972777 | 0.90 | SMN1; SMN2 (0.56) | SMN1; SMN2MAOAMAOBPPARA | |
| SCHEMBL7962725 | 0.81 | SMN1; SMN2 (0.58) | SMN1; SMN2MAOAMAOBPPARAPPARG | |
| SCHEMBL10631228 | 0.79 | MAOA (0.55) | MAOAMAOBBRD4HRH3 | |
| SCHEMBL7962749 | 0.78 | SMN1; SMN2 (0.48) | SMN1; SMN2PPARABRD4PPARGMEN1 | |
| SCHEMBL8360671 | 0.76 | MAOA (0.55) | MAOAMAOBPPARAPPARGMEN1 | |
| SCHEMBL7951489 | 0.76 | MAOA (0.55) | MAOAMAOBBRD4HRH3 | |
| SCHEMBL9688253 | 0.76 | MAOA (0.57) | SMN1; SMN2MAOAMAOBBRD4MEN1 | |
| SCHEMBL6825600 | 0.76 | MAOA (0.66) | MAOAMAOBBRD4HRH3 | |
| SCHEMBL7527304 | 0.75 | HSD17B10 (0.66) | MAOAMAOBBRD4HRH3 | |
| SCHEMBL8318498 | 0.75 | MAOA (0.51) | MAOAMAOBBRD4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248766-B1 | CARDIOVASCULAR DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-06-19 | — | — | US | disclosed |